Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan

S Kajihara, S Matsuhashi, K Yamamoto… - American journal of …, 1995 - ncbi.nlm.nih.gov
S Kajihara, S Matsuhashi, K Yamamoto, K Kido, K Tsuji, A Tanae, S Fujiyama, T Itoh…
American journal of human genetics, 1995ncbi.nlm.nih.gov
Glycogen storage disease (GSD) type 1a (von Gierke disease) is an autosomal recessive
disorder caused by a deficiency in microsomal glucose-6-phosphatase (G6Pase). We have
identified a novel mutation in the G6Pase gene of a individual with GSD type 1a. The cDNA
from the patient's liver revealed a 91-nt deletion in exon 5. The genomic DNA from the
patient's white blood cells revealed no deletion or mutation at the splicing junction of intron 4
and exon 5. The 3'splicing occurred 91 bp from the 5'site of exon 5 (at position 732 in the …
Abstract
Glycogen storage disease (GSD) type 1a (von Gierke disease) is an autosomal recessive disorder caused by a deficiency in microsomal glucose-6-phosphatase (G6Pase). We have identified a novel mutation in the G6Pase gene of a individual with GSD type 1a. The cDNA from the patient's liver revealed a 91-nt deletion in exon 5. The genomic DNA from the patient's white blood cells revealed no deletion or mutation at the splicing junction of intron 4 and exon 5. The 3'splicing occurred 91 bp from the 5'site of exon 5 (at position 732 in the coding region), causing a substitution of a single nucleotide (G to T) at position 727 in the coding region. Further confirmation of the missplicing was obtained by transient expression of allelic minigene constructs into animal cells. Another eight unrelated families of nine Japanese patients were all found to have this mutation. This mutation is a new type of splicing mutation in the G6Pase gene, and 91% of patients and carriers suffering from GSD1a in Japan are detectable with this splicing mutation.
ncbi.nlm.nih.gov